Irritable Bowel Syndrome Drugs Market Share

North America Market Forecast

The North American irritable bowel syndrome drugs market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed to the increasing frequency of fecal incontinence and the availability of efficient treatment options in the region. For instance, 50 to 70 patients out of every 100 nursing home residents and 18 to 33 patients out of every 100 hospitalized patients, respectively, suffer from fecal incontinence. Fecal incontinence affects 7 to 15 persons out of every 100 who are not patients or residents of nursing homes or hospitals. In addition, the region's supportive health policies and expanding healthcare industry are anticipated to boost the market expansion during the course of the anticipated period.